Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
Clinical development of core pipeline products continues
Wide clinical studies to unlock global potential
Nonclinical and clinical evaluation of monoclonal antibodies and related products intended for the prevention of respiratory syncytial virus disease
公众号
小程序
社群